The growth and differentiation of colon cancer cells can be modulated through PPAR gamma where loss-of-function mutations in PPAR gamma have been shown to be associated with colon cancer, suggesting that activation of this receptor might have an anticancer effect in this disease [47, 48]. The gene discussed is PPARG; the disease is malignant colon neoplasm.